RTN4 and S1PR2 identified as targets for stroke

DISEASE CATEGORY: Neurology

INDICATION: Stroke

A team led by NovaGo Therapeutics co-founder Martin Schwab showed inhibition of RTN4

Read the full 164 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE